Akari Therapeutics Plc ADR

AKTX

8.18

-0.56

-6.4%

After Hours:

8.18

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 9.83
Prev. Close: 8.74
Low/Hi: 8.14 - 10.49
52-Week: 3.18 - 22.20
Volumes
Equity: 3,623,502
90-Day Avg: 201,872
Volatility
Todays Stock Vol: 302.0
20-Day (HV): 159.3
52-Week (HV): 135.7
Fundamental
Div. Yield: 0.0%
Earnings: 22-Nov (Est.)
P/E Ratio:
Market Cap: 102.9 M
Stock Type: Common
ADR: UNITED KINGDOM
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common - ADR (UNITED KINGDOM) | Sector: Healthcare | Industry: Biotechnology

AKTX Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Dec-2016 31-Mar-2016 31-Dec-2015 30-Sep-2015
Net Income 0 -2,985 7,406 -48,736
Change in Working Capital 0 -4,398 -3,443 8,491
Depreciation Amortization Depletion and Accretion 0 9 6 22,310
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 0 -66 -9,806 22,304
Total Cash from Operating Activities 0 -7,441 -6,770 5,303
Capital Expenditures 0 -42 -11 0
Other Investing Cash Flow 0 0 -8 1,411
Total Cash from Investing Activities 0 -42 -19 1,411
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 0 0 0 75,000
Purchase and Retirement of Debt 0 0 -3,053 2,523
Other Financing Cash Flow 0 0 -7 -5,418
Total Cash from Financing Activities 0 0 -3,060 72,104
Exchange Rate Effects 0 -8 -4 126
Net Change in Cash 0 -7,490 -9,853 78,943
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Net Income -18,141 -45,318 -9,648 -3,620
Change in Working Capital -1,450 4,672 263 -1,640
Depreciation Amortization Depletion and Accretion 40 22,325 8 2
Deferred Taxes 0 0 0 0
Other Non-Cash Activities -5,073 13,355 -84 -192
Total Cash from Operating Activities -24,625 -4,966 -9,461 -5,450
Capital Expenditures -55 -11 -57 0
Other Investing Cash Flow -10,012 1,402 -142 0
Total Cash from Investing Activities -10,067 1,392 -199 0
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 0 75,000 8,219 13,103
Purchase and Retirement of Debt 0 -530 0 -1,100
Other Financing Cash Flow 0 -5,426 0 0
Total Cash from Financing Activities 0 69,044 8,219 12,003
Exchange Rate Effects -130 122 0 0
Net Change in Cash -34,821 65,593 -1,441 6,553